Komori
Ono Pharmaceutical (4528) · InitiativeFirst stated

Research support through the Cancer, Immunology and Neuroscience Research Foundation

First written in FY2023. . Latest entry: FY2023.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Research support through a foundation for oncology, immunology and neuroscienceA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023First statedAnnual report

    「Recognition of contributions to the Ono Pharmaceutical Cancer, Immunology and Neurology Research Foundation, established in January 2023」

    The company established a foundation in January 2023 to support research in oncology, immunology and neuroscience, and recorded a contribution during the fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Ono Pharmaceutical's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research support through the Cancer, Immunology and Neuroscience Research Foundation | ONO PHARMACEUTICAL CO.,LTD. (4528) | Komori